Stoke Therapeutics
STOK
STOK
70 hedge funds and large institutions have $825M invested in Stoke Therapeutics in 2020 Q2 according to their latest regulatory filings, with 9 funds opening new positions, 17 increasing their positions, 24 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
70
Holders Change
+3
Holders Change %
+4.48%
% of All Funds
1.44%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.02%
New
9
Increased
17
Reduced
24
Closed
6
Calls
$608K
Puts
$5K
Net Calls
+$603K
Net Calls Change
+$603K
Top Buyers
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$11.5M |
| 2 |
RG
Redmile Group
San Francisco,
California
|
+$8.02M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
+$7.28M |
| 4 |
VOYA Investment Management
Atlanta,
Georgia
|
+$3.43M |
| 5 |
Millennium Management
New York
|
+$3.35M |
Top Sellers
| 1 |
Janus Henderson Group
London,
United Kingdom
|
-$12.2M |
| 2 |
Victory Capital Management
San Antonio,
Texas
|
-$7.81M |
| 3 |
BlackRock
New York
|
-$3.73M |
| 4 |
GGHC
Gilder Gagnon Howe & Co
New York
|
-$2.79M |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
-$2.76M |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
76
UBS Group
Zurich,
Switzerland
| – | -$100K | -4,380 | Closed |
|